Literature DB >> 34974110

High glutamate concentration reverses the inhibitory effect of microglial adenosine 2A receptor on NLRP3 inflammasome assembly and activation.

Hao Du1, Yan Tan2, Chang-Hong Li1, Yan Zhao3, Ping Li3, Ya-Lei Ning3, Ruo-Bing Gao1, Bo Wang1, Yan Peng1, Si-Wei Tan1, Zhi-Zhong Huang1, Xing Chen1, Nan Yang1, Fa-Bo Shan1, Ren-Ping Xiong1, Yuan-Guo Zhou4.   

Abstract

NLRP3 inflammasome plays a crucial role in the innate immune system. Our group previously reported that the microglial adenosine 2A receptor (A2AR) regulates canonical neuroinflammation, which is affected by the glutamate concentration. However, the regulatory effect of A2AR on NLRP3 inflammasome and the effects of glutamate concentration remain unknown. Therefore, we aimed to investigate the regulatory effect of microglial A2AR on NLRP3 inflammasome assembly and activation as well as the effects of glutamate concentration on the inflammasome assembly and activation. Experiments were conducted on magnetically sorted primary microglia from P14 mice. The results showed that pharmacological A2AR activation ameliorated NLRP3 activation under no or low glutamate concentrations, but this effect was reversed by high glutamate concentrations. Moreover, the mRNA levels of NLRP3 inflammasome-related genes were not affected by A2AR activation or the glutamate concentration. We further demonstrated that A2AR activation inhibited the interaction between NLRP3 and caspase 1 under no or low glutamate concentrations while promoting their interaction under high glutamate concentrations. The oligomerization of ASC also showed a similar trend. In conclusion, our findings proved that the high glutamate concentration could reverse the inhibition of A2AR on NLRP3 inflammasome activation by modulating its assembly, which provides new insights into the regulatory effect of A2AR on neuroinflammation under different pathological conditions.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine 2A receptor; Glutamate; Microglia; NLRP3 inflammasome

Mesh:

Substances:

Year:  2021        PMID: 34974110     DOI: 10.1016/j.neulet.2021.136431

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Authors:  Stefania Merighi; Manuela Nigro; Alessia Travagli; Silvia Pasquini; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi; Stefania Gessi
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

2.  Ablation of GSDMD Attenuates Neurological Deficits and Neuropathological Alterations After Traumatic Brain Injury.

Authors:  Hao Du; Chang-Hong Li; Ruo-Bing Gao; Xiao-Qing Cen; Ping Li
Journal:  Front Cell Neurosci       Date:  2022-05-20       Impact factor: 6.147

Review 3.  Adenosine receptor signalling in Alzheimer's disease.

Authors:  Phuc N H Trinh; Jo-Anne Baltos; Shane D Hellyer; Lauren T May; Karen J Gregory
Journal:  Purinergic Signal       Date:  2022-07-23       Impact factor: 3.950

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.